Compania de Minas Buenaventura SAA ADR (BVN)vsVersamet Royalties Corporation Common Stock (VMET)
BVN
Compania de Minas Buenaventura SAA ADR
$27.99
-1.20%
BASIC MATERIALS · Cap: $7.11B
VMET
Versamet Royalties Corporation Common Stock
$9.13
+2.24%
BASIC MATERIALS · Cap: $926.14M
Smart Verdict
WallStSmart Research — data-driven comparison
Compania de Minas Buenaventura SAA ADR generates 3030% more annual revenue ($2.32B vs $74.18M). VMET leads profitability with a 49.9% profit margin vs 49.2%. BVN trades at a lower P/E of 5.9x. BVN earns a higher WallStSmart Score of 85/100 (A-).
BVN
Exceptional Buy85
out of 100
Grade: A-
VMET
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+24.2%
Fair Value
$53.41
Current Price
$27.99
$25.42 discount
Intrinsic value data unavailable for VMET.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Keeps 49 of every $100 in revenue as profit
Strong operational efficiency at 42.3%
Safe zone — low bankruptcy risk
Every $100 of equity generates 24 in profit
Conservative balance sheet, low leverage
Keeps 50 of every $100 in revenue as profit
Strong operational efficiency at 58.0%
Revenue surging 391.9% year-over-year
Earnings expanding 2123.0% YoY
Reasonable price relative to book value
Areas to Watch
No major concerns identified
Smaller company, higher risk/reward
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : BVN
The strongest argument for BVN centers on P/E Ratio, Profit Margin, Operating Margin. Profitability is solid with margins at 49.2% and operating margin at 42.3%. Revenue growth of 26.5% demonstrates continued momentum.
Bull Case : VMET
The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 49.9% and operating margin at 58.0%. Revenue growth of 391.9% demonstrates continued momentum.
Bear Case : BVN
No major red flags identified for BVN, but monitor valuation.
Bear Case : VMET
The primary concerns for VMET are Market Cap, Altman Z-Score.
Key Dynamics to Monitor
VMET is growing revenue faster at 391.9% — sustainability is the question.
BVN generates stronger free cash flow (289M), providing more financial flexibility.
Monitor OTHER PRECIOUS METALS & MINING industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BVN scores higher overall (85/100 vs 60/100), backed by strong 49.2% margins and 26.5% revenue growth. Both earn "Exceptional Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Compania de Minas Buenaventura SAA ADR
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Compaa de Minas Buenaventura SAA, a precious metals company, is dedicated to the exploration, extraction, concentration, smelting and commercialization of minerals and polymetallic metals in Peru, the United States, Europe and Asia. The company is headquartered in Lima, Peru.
Visit Website →Versamet Royalties Corporation Common Stock
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Viamet Pharmaceuticals Corp (VMET) is an innovative biopharmaceutical company dedicated to the development of advanced therapeutics targeting serious diseases, particularly in the areas of fungal infections and oncology, utilizing its proprietary metalloenzyme-based technology platform. With a robust and diversified clinical pipeline supported by strategic partnerships and a comprehensive intellectual property portfolio, Viamet is strategically positioned for significant growth. The company remains focused on addressing critical unmet medical needs and is committed to enhancing shareholder value through continued therapeutic advancements in its specialized areas.
Compare with Other OTHER PRECIOUS METALS & MINING Stocks
Want to dig deeper into these stocks?